Together, Roche and Biogen paid over $5.5 bil...
Avedro’s long saga with the FDA continues. ...
CEO Wolfgang Tolle joined VisionCare last yea...
Cedric Francois, co-founder, CEO, and preside...
Steven Vold, MD, sees huge advances in MIGs t...
Tom Mitro of Aerie Pharmaceuticals opens up t...
Patrick Mooney, head of Novartis’ US eye ca...
Avedro Inc. went public on Feb. 14, raising $...
Oculis CEO Riad Sherif, who once worked for N...
With more than $100 million raised in venture...